Hvidovre

• Feasibility of short-term temporary discontinuation of serotonin reuptake inhibitors in patients planned for hip or knee arthroplasty Not authorised
  2023-509988-24-00 11 Hip and knee osteoarthritis
• Local Antibiotic Delivery for Community Acquired Pneumonia (LANDCAP 2) Pending
  2024-511420-13-00 4 Community-acquired pneumonia
• STRATIFY II Pending
  2024-515712-45-00 6 Pulmonary embolism
• MENPI: Safety and immunogenicity following meningococcal and pneumococcal immunization among adult people living with HIV. A single center, … Pending
  2024-516961-35-01 11 HIV
• Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults with Non-cystic Fibrosis Bronchiectasis (NCFB) Pending
  2024-518821-13-00 4 Non-cystic Fibrosis Bronchiectasis
• Aciclovir for HSV-2 MENingitis: A double-blinded randomised controlled trial (AMEN) Pending
  2024-520042-31-00 6 HSV-2 meningitis
• Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year Pending
  2025-521590-13-00 5 Moderately to Severely Active Crohn’s Disease
• COPE-CP: The effect of Celecoxib on pain, quality of life, use of opioids, and inflammation in patients suffering from chronic pancreatitis Pending
  2025-522956-25-00 5 Chronic pancreatitis
• Progesterone supplementation after letrozole-stimulated insemination Pending
  2025-524327-53-00 6 Infertility
• RESET C2 Pending
  2026-525214-62-00 4 Localised dMMR Colon Cancer
• Long-term safety and efficacy evaluation of lunsekimig (SAR443765) in adult participants with moderate-to-severe asthma. Recruiting
  2025-522896-27-00 4 2026-05-11 Asthma
• A study to determine the safety and effect of antibodies against hepatitis D (the SAMBA-D study) Recruiting
  2025-522125-36-00 3 2026-04-22 Chronic hepatitis D infection
• A study on the immune response and safety of an investigational chickenpox vaccine and a marketed measles, mumps and rubella vaccine when ad … Recruiting
  2024-518840-18-00 5 2025-12-10 Varicella
• Phase 3 trial of eRapa in patients with familial adenomatous polyposis (FAP) Recruiting
  2025-522946-37-00 5 2025-11-24 Familial adenomatous polyposis (FAP)
• Vedolizumab Subcutaneous Long-term Open-label Extension Study in Pediatric Subjects Recruiting
  2023-508804-39-00 5 2025-10-15 Ulcerative Colitis or Crohn’s Disease
• An RCT investigating hCG priming in women with diminished ovarian reserve Recruiting
  2025-521234-28-00 5 2025-09-10 Infertility, diminished ovarian reserve.
• The AIRTIVITY TM Study: A study to find out whether BI 1291583 helps people with bronchiectasis Recruiting
  2024-518589-29-00 5 2025-08-21 Bronchiectasis
• Empirical Meropenem versus Piperacillin/Tazobactam for Adult Patients with Sepsis (EMPRESS) Recruiting
  2023-509703-33-00 6 2025-06-26 Septic Shock
• The Intensive Care Platform Trial (INCEPT) Recruiting
  2024-516208-41-00 6 2025-06-26 Acute critical illness requiring intensive care unit admission.
• Phase 3 Study of Vedolizumab Subcutaneous in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease Recruiting
  2023-503188-40-00 5 2025-01-06 Active Ulcerative Colitis or Crohn’s Disease
• Clairleaf TM: A study to test long-term treatment with BI 1291583 in people with bronchiectasis who took part in a previous study with this … Recruiting
  2023-503290-38-00 4 2023-09-05 Bronchiectasis
• Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen (TILIA). Recruiting
  2023-507031-38-00 5 2023-01-09 Severe viral lung infections
• AMAZE 1: A research study investigating how well the medicine NNC0487-0111 helps people with excess body weight lose weight Recruiting
  2024-520440-42-00 5 2026-05-07 Obesity
• TRI-AB trial Recruiting
  2024-520251-24-00 6 2026-05-04 Complicated urinary tract infections (cUTI) requiring hospitalisation

Showing 1–24 of 132 trials